Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00129415 · ClinicalTrials.gov registry record · Phase 1
Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions
A Phase 1 study, sponsored by University of Michigan.
- Terminated
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT00129415 is a Phase 1 study that was terminated before completion, run by University of Michigan. The registered enrollment target is 28 participants.
The verdict
NCT00129415, a Phase 1 study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this investigation is to study the effectiveness of longer wavelength UVA1 (340-400nm) or shorter wavelength ultraviolet B \[UVB\] (290-320nm) irradiation in the treatment of inflammatory skin conditions (such as: atopic dermatitis, psoriasis, mycosis fungoides, alopecia areata, stretch marks and urticaria). This research study aims to evaluate the effectiveness of an investigational device which is similar in appearance to a "tanning bed" but which emits ultraviolet irradiation of a specific wavelength known as UVA1. This device has not been approved by the Food and Drug Administration (FDA) for general use in this country, as of yet, but it has been used quite successfully in Europe for several years in treating such conditions as scleroderma, atopic dermatitis, urticaria pigmentosa and other skin conditions. Instead of UVA1 therapy, patients may receive ultraviolet radiation of a specific wavelength known as UVB. UVA1 light is a longer wavelength and therefore a lower energy wavelength than UVB. UVB light is often the light associated with getting a sunburn since it has a higher level of energy. UVB light has been used successfully in the treatment of many skin conditions.
Interventions
- PROCEDURE UVB Irradiation
- PROCEDURE UVA1 Irradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2000-08 |
| Est. Completion | 2011-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00129415
The ClinicalTrials.gov registry entry for NCT00129415 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which UVB Irradiation is the first listed.
NCT00129415 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00129415 about?
NCT00129415 is a clinical study titled "Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions". The purpose of this investigation is to study the effectiveness of longer wavelength UVA1 (340-400nm) or shorter wavelength ultraviolet B \[UVB\] (290-320nm) irradiation in the treatment of inflammatory skin conditions (such as: atopic dermatitis, psoriasis, mycosis fungoides, alopecia areata, stret...
What is the current status of trial NCT00129415?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2000-08. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00129415?
The interventions under investigation include: UVB Irradiation (PROCEDURE), UVA1 Irradiation (PROCEDURE).
Who is sponsoring clinical trial NCT00129415?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.